New Report Highlights Limitations of Immunotherapy for Mesothelioma – Benzinga
|
New Report Highlights Limitations of Immunotherapy for Mesothelioma
Benzinga "Although some of the more recent studies of CTLA-4 inhibitors for mesothelioma have tempered some of the initial excitement, immunotherapy still holds a great deal of promise as part of a combination approach," says Alex Strauss, Managing Editor for … |
